Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second malignancies in children: the usual suspects?

J Moppett1, A Oakhill, A W Duncan

  • 1Department of Paediatric Oncology, Bristol Royal Hospital for Sick Children, St. Michael's Hill, Bristol BS2 8BJ, UK.

European Journal of Radiology
|February 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carboplatinum.

Bristol medico-chirurgical journal (1963)·2017
Same author

Epirubicin.

Bristol medico-chirurgical journal (1963)·2017
Same author

Ifosfamide ±VP16 in Childhood' Malignancy: A Phase II (toxicity) Study.

Bristol medico-chirurgical journal (1963)·2017
Same author

Evaluation of coagulopathy before and during induction chemotherapy for acute lymphoblastic leukaemia, including assessment of global clotting tests.

Blood cancer journal·2017
Same author

Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL.

Bone marrow transplantation·2015
Same author

Breast milk DHA levels in Sri Lankan mothers vary significantly in three locations that have different access to dietary fish.

The Ceylon medical journal·2013

This review examines second malignant neoplasms (SMNs) after childhood cancer treatment, focusing on incidence, genetic factors, and treatment influences. It highlights key primary and secondary cancers, patient risk factors, and diagnostic approaches.

Area of Science:

  • Oncology
  • Pediatric Oncology
  • Cancer Genetics

Background:

  • Childhood cancer survivors face increased risks of developing subsequent neoplasms.
  • Understanding the interplay between primary cancer, treatment modalities, and genetic predisposition is crucial for managing long-term health outcomes.

Purpose of the Study:

  • To provide a comprehensive review of second malignant neoplasms (SMNs) in childhood cancer survivors.
  • To elucidate the incidence, genetic factors, and prognostic implications of SMNs.
  • To identify high-risk patient groups and relevant diagnostic strategies.

Main Methods:

  • Review of current literature on second malignant neoplasms following childhood cancer.
  • Analysis of the influence of primary malignancy type and treatment (chemotherapy, radiotherapy) on SMN development.

Related Experiment Videos

  • Inclusion of case histories with radiological features for diagnostic emphasis.

    • Main Results:

    • Specific primary cancers (Hodgkin's disease, retinoblastoma, acute lymphoblastic leukemia) are associated with distinct SMNs.
    • Common SMNs include CNS tumors, thyroid cancer, osteosarcoma, secondary acute myeloid leukemia, and melanoma.
    • Radiotherapy and chemotherapy are significant etiological agents for SMNs.

    Conclusions:

    • Identifying at-risk individuals is paramount for proactive surveillance and management of SMNs.
    • Genetic factors play a role in susceptibility to developing SMNs.
    • Early diagnosis and screening, particularly focusing on radiological findings, improve outcomes for childhood cancer survivors at risk of SMNs.